Table 5 Association between patients’ characteristics and visual acuity at the final follow-up using submacular hemorrhage as a factor (n = 46).

From: Influence of bevacizumab therapy and intraretinal hemorrhage in long-term outcomes of hemorrhagic retinal arterial macroaneurysm

Morphologic features

P-value*

β

95% confidence interval

Age

0.044

1.159

1.004–1.339

Sex

0.260

  

Diabetes mellitus

0.199

  

Hypertension

0.155

  

Use of anticoagulants

0.423

  

Systolic blood pressure

0.483

  

Diastolic blood pressure

0.865

  

Extent of hemorrhage

0.552

  

Submacular hemorrhage

0.041

9.671

1.041–89.822

Foveal involvement (hemorrhage vs. exudation)

0.841

  

Treatment (intravitreal bevacizumab vs. observation)

0.788

  
  1. *Statistical analysis was performed using binary logistic regression.